Historique
Bulletin de Périodique
Drug and Alcohol Dependence , Vol.114, n°2-3 - April 2011
Paru le :
06/04/2011
Année
2011
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Measuring costs of alcohol harm to others: A review of the literature. Navarro H.J., Doran C.M., Shakeshaft A.P., p. 87-99.
• The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Dodge T., Hoagland M.F., p. 100-109.
• Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Tsoh J.Y., Chi F.W., Mertens J.R., Weisner C.M., p. 110-118.
• The role of Alcoholics Anonymous in mobilizing adaptive social network changes: A prospective lagged mediational analysis. Kelly J.F., Stout R.L., Magill M., Tonigan J.S., p. 119-126.
• Multilevel influences of school and family on alcohol-purchasing behaviors in school-aged children. Chen K.-H., Chen C.-Y., Liu C.-Y., Lin Y.-C., Chen W.J., Lin K.-M., p. 127-133.
• Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment. Arendt M., Munk-Jørgensen P., Sher L., Jensen S.O.W., p. 134-139.
• Cigarette smoking in young adults: The influence of the HTR2A T102C polymorphism and punishment sensitivity. White M.J., Young R.M., Morris C.P., Lawford B.R., p. 140-146.
• Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat. Baumann M.H., Williams Z., Zolkowska D., Rothman R.B., p. 147-152.
• Factors associated with missing data in an experience sampling investigation of substance use determinants. Messiah A., Grondin O., Encrenaz G., p. 153-158.
• Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Bell R.P., Foxe J.J., Nierenberg J., Hoptman M.J., Garavan H., p. 159-168.
• Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders. Kiluk B.D., Nich C., Carroll K.M., p. 169-176.
• Cluster randomised trial of the effectiveness of Motivational Interviewing for universal prevention. McCambridge J., Hunt C., Jenkins R.J., Strang J., p. 177-184.
• Oral ketamine as a positive control in human abuse potential studies. Shram M.J., Sellers E.M., Romach M.K., p. 185-193.
• Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity. Vassileva J., Georgiev S., Martin E., Gonzalez R., Segala L., p. 194-200.
• Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA. Kennedy J., Dipzinski A., Roll J., Coyne J., Blodgett E., p. 201-206.
• WISDM primary and secondary dependence motives: Associations with self-monitored motives for smoking in two college samples. Piasecki T.M., Piper M.E., Baker T.B., Hunt-Carter E.E., p. 207-216.
• Intravenous self-administration of gamma-hydroxybutyrate (GHB) in baboons. Goodwin A.K., Kaminski B.J., Griffiths R.R., Ator N.A., Weerts E.M., p. 217-224.
• Voucher incentives increase treatment participation in telephone-based continuing care for cocaine dependence. Van Horn D.H.A., Drapkin M., Ivey M., Thomas T., Domis S.W., Abdalla O., et al., p. 225-228.
• Nicotine dependence as a moderator of a quitline-based message framing intervention. Fucito L.M., Latimer A.E., Carlin-Menter S., Salovey P., Cummings K.M., Makuch R.W., et al., p. 229-232.
• High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors). Valdez A., Neaigus A., Kaplan C., Cepeda A., p. 233-236.
• Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Guydish J., Tajima B., Chan M., Delucchi K.L., Ziedonis D., p. 237-241.
• Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Demirakca T., Sartorius A., Ende G., Meyer N., Welzel H., Skopp G., et al., p. 242-245.
• Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1[alpha]/CXCL12 in the brain. Benamar K., Palma J., Cowan A., Geller E.B., Adler M.W., p. 246-248.
• Risks associated with crack cocaine smoking among exotic dancers in Baltimore, MD. Sherman S.G., Reuben J., Chapman C.S., Lilleston P., p. 249-252.
• Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats. Rutten K., De Vry J., Bruckmann W., Tzschentke T.M., p. 253-256.
• Measuring costs of alcohol harm to others: A review of the literature. Navarro H.J., Doran C.M., Shakeshaft A.P., p. 87-99.
• The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Dodge T., Hoagland M.F., p. 100-109.
• Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Tsoh J.Y., Chi F.W., Mertens J.R., Weisner C.M., p. 110-118.
• The role of Alcoholics Anonymous in mobilizing adaptive social network changes: A prospective lagged mediational analysis. Kelly J.F., Stout R.L., Magill M., Tonigan J.S., p. 119-126.
• Multilevel influences of school and family on alcohol-purchasing behaviors in school-aged children. Chen K.-H., Chen C.-Y., Liu C.-Y., Lin Y.-C., Chen W.J., Lin K.-M., p. 127-133.
• Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment. Arendt M., Munk-Jørgensen P., Sher L., Jensen S.O.W., p. 134-139.
• Cigarette smoking in young adults: The influence of the HTR2A T102C polymorphism and punishment sensitivity. White M.J., Young R.M., Morris C.P., Lawford B.R., p. 140-146.
• Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat. Baumann M.H., Williams Z., Zolkowska D., Rothman R.B., p. 147-152.
• Factors associated with missing data in an experience sampling investigation of substance use determinants. Messiah A., Grondin O., Encrenaz G., p. 153-158.
• Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Bell R.P., Foxe J.J., Nierenberg J., Hoptman M.J., Garavan H., p. 159-168.
• Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders. Kiluk B.D., Nich C., Carroll K.M., p. 169-176.
• Cluster randomised trial of the effectiveness of Motivational Interviewing for universal prevention. McCambridge J., Hunt C., Jenkins R.J., Strang J., p. 177-184.
• Oral ketamine as a positive control in human abuse potential studies. Shram M.J., Sellers E.M., Romach M.K., p. 185-193.
• Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity. Vassileva J., Georgiev S., Martin E., Gonzalez R., Segala L., p. 194-200.
• Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA. Kennedy J., Dipzinski A., Roll J., Coyne J., Blodgett E., p. 201-206.
• WISDM primary and secondary dependence motives: Associations with self-monitored motives for smoking in two college samples. Piasecki T.M., Piper M.E., Baker T.B., Hunt-Carter E.E., p. 207-216.
• Intravenous self-administration of gamma-hydroxybutyrate (GHB) in baboons. Goodwin A.K., Kaminski B.J., Griffiths R.R., Ator N.A., Weerts E.M., p. 217-224.
• Voucher incentives increase treatment participation in telephone-based continuing care for cocaine dependence. Van Horn D.H.A., Drapkin M., Ivey M., Thomas T., Domis S.W., Abdalla O., et al., p. 225-228.
• Nicotine dependence as a moderator of a quitline-based message framing intervention. Fucito L.M., Latimer A.E., Carlin-Menter S., Salovey P., Cummings K.M., Makuch R.W., et al., p. 229-232.
• High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors). Valdez A., Neaigus A., Kaplan C., Cepeda A., p. 233-236.
• Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Guydish J., Tajima B., Chan M., Delucchi K.L., Ziedonis D., p. 237-241.
• Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Demirakca T., Sartorius A., Ende G., Meyer N., Welzel H., Skopp G., et al., p. 242-245.
• Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1[alpha]/CXCL12 in the brain. Benamar K., Palma J., Cowan A., Geller E.B., Adler M.W., p. 246-248.
• Risks associated with crack cocaine smoking among exotic dancers in Baltimore, MD. Sherman S.G., Reuben J., Chapman C.S., Lilleston P., p. 249-252.
• Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats. Rutten K., De Vry J., Bruckmann W., Tzschentke T.M., p. 253-256.
Dépouillements
Ajouter le résultat à votre sélection
H. J. NAVARRO ;
C. M. DORAN ;
A. P. SHAKESHAFT
|
2011
Dans Drug and Alcohol Dependence (Vol.114, n°2-3, April 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.114, n°2-3, April 2011) Article : Périodique
INTRODUCTION: People other than the drinker experience harmful consequences from alcohol misuse, accounting for part of the economic burden to society. Little has been done on costing harm to others.
AIMS:
1. To recognize the range of costs c[...]
M. ARENDT ;
P. MUNK-JORGENSEN ;
L. SHER ;
S. O. W. JENSEN
|
2011
Dans Drug and Alcohol Dependence (Vol.114, n°2-3, April 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.114, n°2-3, April 2011) Article : Périodique
This is a register-based cohort study of 20,581 individuals in treatment for illicit substance use disorders in Denmark between 1996 and 2006. All in all, 1441 deaths were recorded during 111,445 person-years of follow-up. Standardized mortality[...]